ARCHIVES

Blinatumomab Demonstrates High Response Rate in ALL

This article is from The Cancer Letter archive.

Vol. 35 No. 6 | June 29, 2012

Download PDF Visit The Full Archive

Related Articles

Pharmaceutical Industry: IVAX Official Broder Objects To Orphan Drug Policies of FDA

May 9, 1997

NCAB Working Group To Hold Open And Closed Sessions

January 20, 1995

Groups Urge Passage of Health Care Reform Legislation

January 29, 2010

In Congress: Bills Seek Medicare Coverage for Patients In Cancer Clinical Trials

April 23, 1999

In Brief: McDonough Leaves Komen Foundation; Henderson To Head Salk Institute; Alabama Recruits Two

December 4, 1992

In Brief: Landers Needles Pauling on Vitamin C Study Results; David Goldenberg Heads N.J. Center

October 21, 1983